Abstract
Secondary metabolites obtained from Actinomycetales provide a potential source of many novel compounds with antibacterial, antitumour, antifungal, antiviral, antiparasitic and other properties. The majority of these compounds are widely used as medicines for combating multidrug-resistant Gram-positive and Gram-negative bacterial strains. Members of the genus Streptomyces are profile producers of previously-known secondary metabolites. Actinomycetes have been isolated from terrestrial soils, from the rhizospheres of plant roots, and recently from marine sediments. This review demonstrates the diversity of secondary metabolites produced by actinomycete strains with respect to their chemical structure, biological activity and origin. On the basis of this diversity, this review concludes that the discovery of new bioactive compounds will continue to pose a great challenge for scientists.
Similar content being viewed by others
References
Demain A.L., Sanchez S., Microbial drug discovery: 80 years of progress, J. Antibiot., 2009, 62, 5–16
Donadio S., Monciardini P., Alduina R., Mazza P., Chiocchini C., Cavaletti L., et al., Microbial technologies for the discovery of novel bioactive metabolites, J. Biotechnol., 2002, 99, 187–198
Bérdy J., Bioactive microbial metabolites, J. Antibiot., 2005, 58, 1–26
Lam K.S., New aspects of natural products in drug discovery, Trends in Microbiol., 2007, 15, 279–289
Jensen P.R., Mincer T.J., Williams P.G., Fenical W., Marine actinomycete diversity and natural product discovery, Antonie van Leeuwenhoek, 2005, 87, 43–48
Bull A.T., Stach J.E., Marine actinobacteria: New opportunities for natural product search and discovery, Trends Microbiol., 2007, 15, 491–499
Pimentel-Elardo S.M., Kozytska S., Bugni T.S., Ireland Ch.M., Moll H., Hentschel U., Anti-Parastic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges, Mar. Drugs, 2010, 8, 373–380
Fenical W., Jensen P.R., Developing a new resource for drug discovery: Marine actinomycetebacteria, Nat. Chem. Bol., 2006, 2, 666–673
Penesyan A., Kjelleberg S., Egan S., Development of Novel Drugs from Marine Surface Associated Microorganisms, Mar. Drugs, 2010, 8, 438–459
Blunt J.W., Copp B., Munro M.H., Northcote P.T., Prinsep M.R., Marine natural products, Nat. Prod. Rep., 2010, 27, 165–237
Bhatnagar I., Se-Kwon K., Immense of Excellence: Marine Microbial Bioactive Compounds, Mar. Drugs, 2010, 8, 2673–2701
Simmons T.L., Andrianasolo E., McPhail K., Flatt P., Gerwick W.H., Marine natural products as anticancer drugs, Mol. Canc. Ther., 2005, 4, 333–342
Bentley S.D., Chater K.F., Cerdeño-Tárraga A.M., Challis G.L., Thomson N.R., James K.D., et al., Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2), Nature, 2002, 417, 141–147
Watve M.G., Tickoo R., Jog M.M., Bhole B.D., How many antibiotics are produced by the genus Streptomyces?, Arch. Microbiol., 2001, 176, 386–390
Ruiz B.R., Forero A., Garcia-Huante Y., Romero A., Sánchez M., Rocha D., et al., Production of microbial secondary metabolites: Regulation by the carbon source, Crit. Rev. Microbiol., 2010, 36, 146–167
Singh M.P., Greenstein M., Antibacterial leads from microbial natural products discovery, Curr. Opin. Drug Discov. Develop., 2000, 3, 167–176
Demain A.L., Vaishnav P., Involvement of nitrogencontaining compounds in β-lactam biosynthesis and its control, Critical Rev. Biotechnol., 2006, 26, 67–82
Challis G.L., Hopwood D.A., Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species, PNAS, 2003, 100, 14555–14561
Hopwood D.A., Streptomyces In Nature and Medicine. The antibiotic makers, Oxford University Press, 2007
Duggar B.M., Aureomycin: a product of the continuing search for new antibiotics, Ann. N. Y. Acad. Sc., 1948, 51, 177–181
Cockerill F.R., Wikler M.A., Bush K., Dudley M.N., Eliopoulos G.M., Hardy D.J. et al., Performance Standards for Antimicrobial Susceptibility testing; Twentieth Informational Supplement, Clinical and Laboratory Standards Institute, 2010
Schatz A., Bugie E., Waksman S.A., Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria, Proc. Soc. Exp. Biol. Med., 1944, 55, 66–69
Himbindu M., Annapurna J., Optimization of nutritional requirements for gentamicin production by Micromonospora echinospora, Ind. J. Exper. Biol., 2006, 44, 842–848
Borodina I., Schöller Ch., Eliason A., Nielsen J., Metabolic Network Analysis of Streptomyces tenebrarius, a Streptomyces Species with an Active Entner-Doudoroff Pathway, Appl. Environ. Microbiol., 2005, 71, 2294–2302
Waksman S.A., Lechevalier H.A., Neomycin, a new antibiotic against streptomycin - resistant bacteria, including tuberculosis organisms, Science, 1949, 109, 305–307
McCormick M.H., Stark W.M., Pittenger G.E., McGuire J.M., Vancomycin, a new antibiotic. I. Chemical and biologic properties, Antibiot. Annu., 1956, 606, 1955–1956
Parenti F., Beretta G., Berti M., Arioli V., Teichomycin, New antibiotics from Actinoplanes teichomyceticus, nov. sp., 1. Description of the producer strain, fermentation studies and biological properties, J. Antibiot., 1978, 31, 276–281
McGuire J.M., Bunch R.L., Anderson R.C., Boaz H.E., Flynn E.H., Powell H.M., et al., “Ilotycin” a new antibiotic, Antibiot. Chemother., 1952, 2, 281–283
Hazen E.L.; Brown R. Fungicidin, an antibiotic produced by a soil actinomycete. Proc. Soc. Exp. Biol. Med., 1951, 76, 93–97
Kirst H.A., Macrolide antibiotics in food-animal health, Expert Opin. Investig. Drugs, 1997, 6, 103–118
Hendlin D., Stapley E.O., Jackson M., Wallick H., Miller A.K., Wolf F.J., et al., Phosphonomycin, a new antibiotic produced by strains of Streptomyces, Science, 1969, 166, 122–123
Nett M., Ikeda H., Moore B.S., Genomic basis for natural product biosynthetic diversity in the actinomycetes, Nat. Prod. Rep., 2009, 26, 1362–1384
Bertasso M., Holzen Kämpfer M., Zeeck A., Dall’Antonia F., Fiedler H.P., Bagremycin A and B, Novel Antibiotics from Streptomyces spTü 4128, J. Antibiot., 2001, 54, 730–736
Newman, D.J., Cragg, G.M., Natural products as sources of new drugs over the last 25 years, J. Nat. Prod., 2007, 70, 461–477
Demain A.L. History of Industrial Biotechnology. Industrial Biotechnology: Sustainable Growth and Economic Success, Wiley-VCH Verlag GmbH & Co. KGaA, 2010
Garcia-Mendoza C., Studies on the mode of action of etamycin (Viridogrisein), Biochim. Biophys. Acta., 1965, 97, 394–396
Haste N.M., Perera V.R., Maloney K.N., Tran D.N., Jensen P., Fenical W., Nizet V., et al., Activity of the streptogramin antibiotic etamycin against methicillin-resistant Staphylococcus aureus, J. Antibiot., 2010, 63, 219–224
Kitani S., Yamauchi T., Fukshima E., Kwon Lee Ch., Ningsih F., Kinoshita H., et al., Characterization of varM Encoding Type II ABC Transporter in Streptomyces Virginiae, a Virginiamycin M1 Producer, Actinomycetologica, 2010, 24, 51–57
Metzger R., Bonatti H., Sawyer R., Future trends in the treatment of serious gram-positive infections, Drugs Today (Barc), 2009, 45, 33–45
Balz R.H., Miao V., Wrigley S.K., Natural products to drugs: daptomycin and related lipopeptide antibiotics, Nat. Prod. Rep., 2005, 22, 717–741
Miao V., Coëffet-LeGal M., Brian P., Brost R., Penn J., Whiting A., et al., Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry, Microbiology, 2005, 151, 1507–1523
Nicolaou K.C., Tria G.S., Edmonds D.J., Kar M., Total Syntheses of (±)-Platencin and (−)-Platencin, J. Am. Chem. Soc., 2009, 131, 15909–15917
Junker B., Walker A., Hesse M., Lester M., Christensen J., Connors N., Actinomycetes scaleup for the production of antibacterial, nocathiacin, Biotechnol.Prog., 2009, 25, 176–188
Zhang C., Zink DL., Ushio M., Burgess B., Onishi R., Masurekar P., et al., Isolation, structure, and antibacterial activity of thiazomycin A, a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa, Bioorg. Med. Chem., 2008, 16, 8818–8823
Singh SB., Occi J., Jayasuriya H., Herath K., Motyl M., Dorso K., et al., Antibacterial evaluations of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa, J. Antibiot., 2007, 60, 565–71
Solecka J., Rajnisz A., Laudy A.E., A novel isoquinoline alkaloid, DD-carbxypeptidase inhibitor, with antibacterial aitvity isolated from Streptomyces sp. 8812. Part I: Taxonomy, isolation and biological activities, J. Antibiot., 2009, 62, 575–580
Solecka J., Sitkowski J., Bocian W., Kawęcki R., Kozerski L., A novel isoquinoline alkaloid, DD-carbxypeptidase inhibitor, with antibacterial activity isolated from Streptomyces sp. 8812. Part II: Physicochemical properties and structure elucidation, J. Antibiot., 2009, 62, 581–585
Hashizume H.; Adachi H.; Igarashi M.; Nishimura Y.; Akamats Y. Biological activities of pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp., J. Antibiot., 2010, 63, 279–283
McArthur K.A.; Mitchell S.S.; Tsueng G.; Rheingold A.; White D.J.; Grodberg J., et al., Lynamycins A-E, chlorinated bisindolepyrrole antibiotics from a novel marine actinomycete, J. Nat. Prod., 2008, 71, 1732–1737
Carlson J.C., Li S., Burr D.A., Sherman D.H., Isolation and Characterization of Tirandamycins from Marine-Derived Streptomyces sp., J. Nat. Prod., 2009, 72, 2076–2079
Kwon H.C., Kauffman C.A., Jensen P.R., Fenical W., Marinomycin A-D, antitumour antibiotics of a new structure class from a marine actinomycete of the recently discovered genus “Marinispora”, J. Am. Chem. Soc., 2006, 128, 1622–1632
Roh H., Uguru G.C., Ko H.J., Kim S., Kim B.Y., Goodfellow M., et al, Genome sequence of the abyssomicin- and proximicin-producing marine actinomycete Verrucosispora maris AB-18-032, J. Bacteriol., 2011, 193, 3391–2
Fiedler H.P., Bruntner C., Bull A.T., Ward A.C., Goodfellow M., Potterat O., et al., Marine actinomycetes as a source of novel secondary metabolites, Antonie van Leeuwenhoek, 2005, 87, 37–42
Bister B., Bischoff D., Ströbele M., Riedlinger J., Reicke A., Wolter F., et al., Abyssomycin C-A polycyclic antibiotic from a marine Verrucosispora strain as an inhibitor of the p-aminobenzoic acid/tetrahydrofolate biosynthesis pathway, Angew. Chem. Int. Ed., 2004, 43, 2574–2576
Hohmann C., Schneider K., Bruntner C., Brown R., Jones A.L., Goodfellow M., et al., Albidopyrone, a new α-pyrone-containing metabolite from marinederive Streptomyces sp. NTK 227, J. Antibiot., 2009, 62, 75–79
Huang H., Wu X., Yi S., Zhou Z., Zhu J., Fang Z., et al., Rifamycin S and its geometric isomer produced by a newly found actinomycete, Micromonospora rifamycinica, Antonie van Leeuwenhoek, 2009, 95, 143–148
Xie Y., Xu H., Sun Ch., Yu Y., Chen R., Two novel nucleosidyl-peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp. SS, J. Antibiotic., 2010, 63, 143–146
Tohyama S., Takahashi Y., Akamatsu Y., Biosynthesis of amycolamicin: the biosynthetic origin of a branched α-aminoethyl moiety in the unusual sugar amycolose, J. Antibiot., 2010, 63, 147–149
El-Gendy M.M.A., Hawas U.W., Jaspars M., Novel Bioactive Metabolites from a Marine Derived Bacterium Nocardia sp. ALAA 2000, J. Antibiot., 2008, 61, 379–386
Parry R., Nishino S., Spain J., Naturally-occurring nitro compounds, Nat. Prod. Rep., 2011, 28, 152–167
Tee E.H.L., Karoli T., Ramu S., Huang J.X., Butler M.S., Cooper M.A., Synthesis of Essramycin and Comparison of Its Antibacterial Activity, J. Nat. Prod., 2010, 73, 1940–1942
Yu Z., Zhao L.X., Jiang Ch.L., Duan Y., Wong L., Carver K.C., et al., Bafilomycins produced by an endophytic actinomycete Streptomyces sp., YIM56209, J. Antibiot., 2011, 64, 159–162
Werner G., Hagenmaier H., Metabolic products of microorganisms.224, Bafilomycins, a new Group of Macrolide Antibiotics, J. Antibiot., 1984, 37, 110–117
Venkat R.M., Liu J., Sunga M., White D.J., Grodberg J., Teisan S., et al., Lipoxazolidinones A, B and C: Antibacterial 4-Oxazolidinones from a Marine Actinomycete Isolated from a Guam Marione Sediment, J. Nat. Prod., 2007, 70, 1454–1457
Abdalla M.A., Helmke E., Laatsch H., Fujianmycin C, A Bioactive Angucyclinone from a Marine Derived Streptomyces sp. B6219 [1], Nat. Prod. Comm., 2010, 5, 1917–1920
Waksman S.A., Woodruff H.B., Actinomyces antibioticus, a new soil organism antagonistic to pathogenic and non-pathogenic bacteria, J. Bacteriol., 1941, 42, 231–249
Arcamone F., Cassinelli G., Fantini G., Grein A., Orezzi P., Pol C., et al., Adriamycin, 14-Hydroxydaunomycin, a new antitumor antibiotic from Streptomyces peucetius var. caesius, Biotechnol. Bioeng., 1969, 11, 1101–1110
Ishizuka M., Takayama H., Takeuchi T., Umezawa H., Activity and toxicity of bleomycin, J. Antibiot., 1967, 20, 15–24
Schein P.S., Macdonald J.S., Hot D.W., Wooley P.V., The FAM (5-fluorouracil, adriamycin, mitomycin C) and SMF (streptozotocin, mitomycin C, 5-fluorouracil) chemotherapy regiment, In: Carter S.K., Crooke S.T., Alder N.A. (Eds.), Mitomycin C: Current Status and New Developments, Academic Press, New York, 1979
Wang Z., Gleichman H., GLUTS2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice, Diabetes, 1998, 47, 50–56
Walker S., Landovitz R., Ding W.D., Ellestad G. A., Kahne D., Cleavage behavior of calicheamycin gamma 1 and calicheamycin T., Proc. Natl. Acad. Sci. USA, 1992, 89, 4608–4612
Zhang H., Sun G.S., Li X., Pan H.L., Zhang Y.S., A New Geldanamycin Analogue from Streptomyces hygroscopicus, Molecules, 2010, 15, 1161–1167
Gorajana A., Venkatesan M., Vinjamuri S., Kurada B.V., Peela S., Jangam P., et al., Resistoflavine, cytotoxic compound from a marine actinomycete, Streptomyces chibaensis AUBN1/7, Microbiol Res., 2007, 162, 322–327
Cho J.Y, Williams P.G., Kwon H.C., Jensen P.R., Fenical W., Lucentamycins A-D, cytotoxic peptides from the marine-derived actinomycete Nocardiopsis lucentensis, J. Nat. Prod., 2007, 70, 1321–1328
Hawas U.W., Shaaban M., Shaaban K.A., Speitling M., Maier A., Ketler G., et al., Mansouramycins A-D, cytotoxic isoquinolinequinones from marine streptomycete, J. Nat. Prod., 2009, 72, 2120–2124
Pérez M., Crespo C., Schleissner C., Rodríguez P., Zúñiga P., Reyes F., Tartrolon D, a cytotoxic macrodiolide from marine-derived actinomycete Streptomyces sp. MDG-04-17-069, J. Nat. Prod., 2009, 72, 2192–2194
Hohmann C., Schneider K., Brutner C., Irran E., Nicholson G., Bull A.T., et al., Carboxamycin, a new antibiotic of the benzoxazole family and phosphodiesterase inhibitor, produced by deep-sea strain Streptomyces sp, NTK 937, J Antibiot., 2009, 62, 99–104
Abdel-Mageed W.M., Milne B.F., Wagner M., Schumacher M., Sandor P., Pathom-aree W., Dermacozines, a new phenazine family from deep sea dermacocci isolated from Mariana Trench sediment, Org. Biomol. Chem., 2010, 8, 2352–2362
Fiedler H-P., Bruntner C., Riedlinger J., Bull A.T., Knutsen G., Goodfellow M., et al., Proximicins A, B and C, novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosipora, J. Antibiot., 2008, 61, 158–163
Izumikawa M., Khan S.T., Komaki H., Takagi M., Shin-ya K., JBIR-31, a new teleocidin analog, produced by salt-requiring Streptomyces sp. NBRC 105896 isolated from a marine sponge, J. Antibiot., 2010, 63, 33–36
Fujiwara T., Nagai A., Takagi M., Shin-ya K., JBIR-69, a new metabolite from Streptomyces sp. OG05, J. Antibiot., 2010, 63, 95–96
Motohashi K., Takagi M., Yamamura H., Hayakawa M., Shin-ya K., A new angucycline and a new butenolide isolated from lichen-derived Streptomyces spp., J.Antibiot., 2010, 63, 545–548
Motohashi K., Takagi M., Shin-ya K., Tetracenoquinocin and 5-iminoaranciamycin from a Sponge-Derived Streptomyces sp. SP080513GE-26, J. Nat. Prod., 2010, 73, 755–758
Schneemann I., Kajahn I., Ohlendorf B., Zinecker H., Erhand A., Nagel K., et al., Mayamycin, a Cytotoxic Polyketide from Streptomyces Strain Isolated from Marine Sponge Halichondria Panicea. J. Nat. Prod., 2010, 73, 1309–1312
Trejo W.H., Bennett R.E., Streptomyces nodosus sp. N., the amphotericin - producing organism, J Bacteriol., 1963, 85, 436–439
Kimura K., Bugg T.D.H., Recent advances in antimicrobial nucleoside antibiotics targeting cell wall biosynthesis, Nat. Prod. Rep., 2003, 20, 252–273
Hector R.F., Compounds active against cell walls of medically important fungi, Clin. Microbiol. Rev., 1993, 6, 1–21
Liao G., Li J., Li L., Yang H., Tian Y., Tan H., Selectively improving nikkomycin Z producton by blocking the imidazolone biosynthetic pathway of nikkomycin X and uracil feeding in Streptomyces ansochromogenes, Microb. Cell Fact., 2009, 8, 61
Yang P.W., Li M.G., Zhao J.Y., Zhu M.Z., Shang H., Li J.R., et al., Oligomycins A and C, major secondary metabolites isolated from the newly isolated strain Streptomyces diastaticus, Folia Microbiol., 2010, 55, 10–16
Sehgal S.N., Baker H., Vézina C., Rapamycin (AY-22989), a new antifungal antibiotic.II Fermentation, isolation and characterization, J. Antibiot., 1975, 28, 727–733
Park S.R., Yoo Y.J., Ban Y.H., Yoon Y.J., Biosynthesis of rapamycin and its regulation: past achievements and recent progress, J. Antibiot., 2010, 63, 434–441
Prapagdee B., Kuekulvong C., Mongkolsuk S., Antifungal potential of extracellular metabolites produced by Streptomyces hygroscopicus against phytopathogenic fungi, Int. J. Biol. Sci., 2008, 4, 330–337
Taechowisan T., Chunhua L., Shen Y., Lumyong S., Secondary metabolites from endophytic Streptomyces aureofaciens CMUAc130 and their antifungal activity, Microbiol., 2005, 151, 1691–1695
Schleger R., Thrum H., Zielinski J., Borowski E.J., The structure of roflamycin. A new polyene macrolide antifungal antibiotic., J.Antibiot., 1981, 34, 122–123
Wu X., Huang H., Chen G., Sun Q., Peng J., Zhu J., et al., A novel antibiotic produced by Streptomyces noursei Da07210, Antonie van Leeuwenhoek, 2009, 96, 109–112
Kavitha A., Prabhakar P., Vijayalakshmi M., Venkateswarlu Y., Purification and biological evaluation of the metabolites produced by Streptomyces sp TK-VL_333., Res. Microbiol., 2010, 161, 335–345
Mishima H., Ide J., Muramatsu S., Ono M, Milbemycins, a new family of macrolide antibiotics. Structure determination of milbemycins D,E,F,G,H,J and K., J.Antibiotics, 1983, 36, 980–990
Hotson I.K., The avermectins: A new family of antiparasitic agents, J. S. Afr. Vet. Assoc., 1982, 53, 87–90
Sun Y., Zhou X., Tu G., Deng Z., Identification of a gene cluster encoding meilingmycin biosynthesis among multiple polyketide synthase contigs isolated from Streptomyces nanchangensis NS3226., Arch. Microbiol., 2003, 180, 101–107
Pimentel-Elardo S.M., Buback V., Gulder T.A.M., Bugni T.S., Reppart J., Bringmann G., New Tetromycin Derivatives with Anti-Trypanosomal and Protease Inhibitory Activities, Mar. Drugs, 2011, 9, 1682–1697
Niitsuma M., Hashida J., Iwatsuki M., Mori M., Ishiyama A., Namatame M., et al., Sinefungin VA and dehydrosinefungin V, new antitrypanosomal antibiotics produced by Streptomyces sp. K05-0178, J. Antibiot., 2010, 63, 673–679
Takatsuki A., Tamura G., Tunicamycin a new antibiotic. II Some biological properties of the antiviral activity of tunicamycin, J. Antibiot., 1971, 24, 224–231
Takagi M., Motohashi K., Nagai A., Izumikawa M., Tanaka M., Fuse S., et al., Anti-influenza virus compound from Streptomyces sp. RI18, Org. Lett., 2010, 12, 4664–4646
Wehmeier U.F, Piepersberg W., Biotechnology and molecular biology of the alpha-glucosidase inhibitor acarbose, Appl Microbiol Biotechnol., 2004, 63, 613–25
Weibel E. K., Hadvary P., Hochuli E., Kupfer E., Lengsfeld H., Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. Producing organism, Fermentation, Isolation and Biological Activity, J. Antibiot., 1987, 8, 1081–1085
Aggarwala D., Fernandez M. L., Solimanb G.A., Rapamycin, an mTOR inhibitor, disrupts triglyceride metabolism in guinea pigs, Metabolism, 2006, 55, 794–802
Kino T., Hatanaka, H., Hashimoto, M., Nishiyama, M., Goto, T., Okuhara, et al., FK-506, a novel immunosuppressant isolated from a Streptomyces. Fermentation, isolation, and physiochemical and biological characteristics, J. Antibiot., 1987, 40, 1249–1255
Kirst H.A., The spinosyn family of insecticides: realizing the potential of natural product research., J. Antibiot., 2010, 63, 101–111
Hayakaa M., Yamamura H., Nakagawa Y., Kawa Y., Hayashi Y., Misonou T., et al., Taxonomic diversity of Actinomycetes Isolated from Swine Manure Compost, Actinomycetologica, 2010, 24, 58–62
Zhang J., Marcin C., Shifflet M.A., Salmon P., Brix T., Greasham R., et al., Development of a defined medium fermentation process for physostigmine production by Streptomyces griseofuscus, Appl. Microbiol. Biotechnol., 1996, 44, 568–575
Hayakawa Y., Yamazaki Y., Kurita M., Kawasaki T., Takagi M., Shin-ya K., Flaviogeranin, a new neuroprotective compound from Streptomyces sp, J. Antibiot., 2010, 63, 379–380
Motohashi K., Toda T., Sue M., Furihata K., Shizuri Y., Matsuo Y., et al., Isolation and structure elucidation of tumescenamides A and B, two peptides produced by Streptomyces tumescens Ym23-260, J. Antibiot., 2010, 63, 549–552
Baltz R. H., Antimicrobials from Actinomycetes: Back to the Future, Microbe, 2007, 2, 125–131
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Solecka, J., Zajko, J., Postek, M. et al. Biologically active secondary metabolites from Actinomycetes. cent.eur.j.biol. 7, 373–390 (2012). https://doi.org/10.2478/s11535-012-0036-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11535-012-0036-1